.rll-youtube-player .play{--wpr-bg-3e85189d-fbef-4288-afc3-7c13110a39bb: url('https://www.stocksregister.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-d9ba4e9b-d52f-417f-9176-4cdc3fa08925: url('https://www.stocksregister.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Tag: Regulus Therapeutics Inc.

Finance

Regulus Therapeutics Inc’s Decline Of -1.32% Makes The Stock Worth Considering Again

Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $1.49 on Wednesday, January 08 with a fall of -1.32% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $1.51 and 5Y monthly beta

Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.

Tag: Regulus Therapeutics Inc.

Regulus Therapeutics Inc’s Decline Of -1.32% Makes The Stock Worth Considering Again

Quick Links

Categories

All rights reserved ©2024, Powered by Smart TechOne